1. Home
  2. HI vs ANIP Comparison

HI vs ANIP Comparison

Compare HI & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hillenbrand Inc

HI

Hillenbrand Inc

HOLD

Current Price

$31.98

Market Cap

2.2B

ML Signal

HOLD

ANIP

ANI Pharmaceuticals Inc.

HOLD

Current Price

$76.02

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HI
ANIP
Founded
2007
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
1.8B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
HI
ANIP
Price
$31.98
$76.02
Analyst Decision
Hold
Strong Buy
Analyst Count
3
6
Target Price
$32.00
$107.33
AVG Volume (30 Days)
1.0M
459.0K
Earning Date
02-04-2026
02-27-2026
Dividend Yield
2.85%
N/A
EPS Growth
N/A
N/A
EPS
0.61
1.67
Revenue
$2,673,800,000.00
$826,880,000.00
Revenue This Year
N/A
$44.19
Revenue Next Year
$2.62
$11.25
P/E Ratio
$52.46
$47.71
Revenue Growth
N/A
48.87
52 Week Low
$18.36
$54.10
52 Week High
$35.48
$99.50

Technical Indicators

Market Signals
Indicator
HI
ANIP
Relative Strength Index (RSI) 69.82 35.03
Support Level $31.84 $78.38
Resistance Level $31.93 $83.80
Average True Range (ATR) 0.05 2.77
MACD 0.00 -0.45
Stochastic Oscillator 88.89 0.10

Price Performance

Historical Comparison
HI
ANIP

About HI Hillenbrand Inc

Hillenbrand Inc is a industrial company that provides engineered processing equipment and solutions to customers around the world. The company operates through two segments. The Advanced Process Solutions segment designs, develops, manufactures, and services engineered industrial equipment and also provider of engineered process and material handling equipment, systems, and aftermarket parts and services for a variety of industries, including durable plastics, food, and recycling. Molding Technology Solutions has a comprehensive product portfolio that includes injection molding and extrusion equipment, It earns it revenue from Advanced Process Solutions, and Geographically from America, following by Asia and EMEA.

About ANIP ANI Pharmaceuticals Inc.

ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.

Share on Social Networks: